Quick Takeaways
- FMR LLC filed SCHEDULE 13G for TRAVERE THERAPEUTICS INC COMMON STOCK (TVTX).
- Disclosed ownership: 12%.
- Date of event: 31 Dec 2025.
FMR LLC - 31 Dec 2025 SCHEDULE 13G Report for TRAVERE THERAPEUTICS INC COMMON STOCK (TVTX)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- TVTX
- Shares outstanding
- 90,318,827 shares
- Disclosed Ownership
- 10,567,303 shares
- Ownership
- 12%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Jan 2026, 09:09:46 UTC
- Date of event
- 31 Dec 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 12% ownership in TRAVERE THERAPEUTICS INC COMMON STOCK (TVTX) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jan 2026, 09:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 12% | 10,567,303 | 10,224,164 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 12% | 10,567,303 | 0 | 0 | Stephanie J. Brown | Duly authorized under Power of Attorney effective as of January 26, 2023, by and on behalf of Abigail P. Johnson** |